FDA Advisory Committee to Review Adolor's NDA for Entereg

Adolor Corp. and GlaxoSmithKline said that the Gastrointestinal Drugs Advisory Committee to the FDA will review Adolor's New Drug Application or NDA for Entereg or alvimopan on January 23, 2008.
TradingMarkets